期刊文献+

血清S100B自身抗体在肺癌脑转移中的应用价值 被引量:1

Application value of serum S100B autoantibody in lung cancer with brain metastasis
原文传递
导出
摘要 目的检测肺癌脑转移患者血清S100B自身抗体水平,探讨其在肺癌脑转移中的应用价值。方法建立检测S100B抗体的间接ELISA方法,分别检测肺癌脑转移组(111例)、肺癌其他转移组(32例)、肺癌无转移组(53例)及对照组(40例)的血清S100B抗体水平,比较各组间差异并制作ROC曲线。结果肺癌脑转移组S100B抗体水平高于肺癌无转移组、肺癌其他转移组和对照组(P<0.05);肺癌无转移组与肺癌其他转移组、对照组S100B抗体水平差异无统计学意义(P>0.05)。肺癌脑转移组S100B抗体水平与病理分型、肿瘤年限、年龄、性别、吸烟史均无关(P>0.05)。S100B抗体诊断肺癌脑转移的AUC为0.704,敏感度为48.6%,特异度为86.4%。结论S100B抗体诊断肺癌脑转移具有一定的灵敏度和特异性,能鉴别肺癌脑转移和其他部位的转移,且不受病理分型、肿瘤年限等因素的影响,具有较大的临床价值。 Objective To detect the levels of serum S100 B autoantibody in patients with brain metastases of lung cancer,and explore the application value of S100 B autoantibody in lung cancer with brain metastases.Methods An indirect ELISA was established,the level of serum S100 B autoantibody was detected respectively in the brain metastasis of lung cancer group(111 cases),the lung cancer without metastasis group(53 cases),the lung cancer with other parts metastasis group(32 cases)and the control group(40 healthy volunteers).ROC Curve was used to evaluate the assay.Results The level of S100 B antibody in lung cancer brain metastasis group was higher than that in lung cancer non-metastasis group,other lung cancer metastasis group and control group(P<0.05).There was no statistical significance on the difference in S100 B antibody level between the lung cancer non-metastasis group,other lung cancer metastasis groups and the control group(P>0.05).The level of S100 B antibody in the lung cancer brain metastasis group was not correlated with pathological type,tumor age,age,gender and smoking history(P>0.05).The AUC,sensitivity and specificity of S100 B antibody in the diagnosis of lung cancer brain metastasis were respectively 0.704,48.6%and 86.4%.Conclusion S100 B autoantibody has a certain sensitivity and specificity in the diagnosis of brain metastasis of lung cancer.It can distinguish between the brain metastasis of lung cancer and the lung cancer with other parts metastasis,and it is not affected by the factors such as pathological type and tumor age.Therefore,the serum S100 B autoantibody is of great clinical value for brain metastases from lung cancer.
作者 张丽红 王宏斌 胡良峰 ZHANG Li-hong;WANG Hong-bin;HU Liang-feng(Clinical Laboratory,Shaoxing People's Hospital,Shaoxing,Zhejiang 312000,China)
出处 《中国卫生检验杂志》 CAS 2020年第14期1713-1715,共3页 Chinese Journal of Health Laboratory Technology
基金 浙江省基础公益研究计划项目(LGF19H200004) 浙江省医药卫生科技平台项目(2017RC030)。
关键词 S100B自身抗体 肺癌脑转移 受试工作曲线 S100B autoantibody Brain metastasis of lung cancer ROC curve
  • 相关文献

参考文献3

二级参考文献25

  • 1Donalo R. Functional roles of S100 proteins calcium-binding protein of EF-hand type[J]. Biophys Acta, 1999,1450(3) : 191-231.
  • 2Poduslo J F, Gurran G L, Berg C T. Macromolecular permeability across the blood-nerve and blood-brain barrier[ J ]. Proc Nail Aead Sci USA,1994,91 : 5705-5709.
  • 3Schettino C, Bareschino M A, Rossi A, et al, Targeting angiogen?esis for treatment of NSCLC brain metastases [J]. CUIT Cancer Drug Targets, 2012,12(3) :289 -99.
  • 4Sacco PC, Maione P, Rossi A, et al. Combination of radiotherapy and targeted therapies in the treatment of locally advanced non?small cell lung cancer[J].Target Oncol, 2011 ,6(3) :171 -80.
  • 5Tucker Z C, Laguna B A, Moon E, et al. Adjuvant immunothera?py for non-small cell lung cancerj L]. Cancer Treat Rev, 2012,38 (6):650-61.
  • 6Saijo N. Problems ivolved in the clinical trials for non-small cell lung cancinoma] JJ. Cancer Treat Rev, 2012,38 (3) : 194 - 202.
  • 7Jemal A, Bray F, Center M M, et al. Global cancer statistics [J] . Cancer J Clin, 2011 ,61 (2) : 69 - 90.
  • 8Yamanaka R. Medical management of brain metastases from lung cancer (Review) [J]. Oncol Rep, 2009,22(6) :1269 -76.
  • 9Okada M, Sakamoto T, Nishio W, et al. Characteristics and prog- nosis of patients after resection of non-small cell lung carcinoma measuring 2 ern or less in greatest dimension [J]. Cancer, 2003, 98(3) :535 -41.
  • 10Yu Z, Chen X Z, Cui L H, et al. Prediction of lung cancer based on serum biomarkers by gene expression programming methods [J] . Asian Pac J Cancer Prev, 2014,15(21) :9367 -73.

共引文献185

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部